FOXO1
Chr 13Somaticforkhead box O1
Also known as: FKH1, FKHR, FOXO1A
FOXO1 encodes a forkhead transcription factor that regulates metabolic homeostasis, glucose metabolism, and cell survival in response to insulin signaling and oxidative stress. Somatic translocations involving FOXO1 cause alveolar rhabdomyosarcoma, a malignant soft tissue tumor that typically affects children and adolescents. The gene is highly constrained against loss-of-function variants (pLI 0.997), indicating it is essential for normal cellular function.
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Highly LoF-intolerant (top ~10% of genes)
Mild missense constraint
The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).
Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.
ClinVar Variant Classifications
146 submitted variants in ClinVar
Classification Summary
Curated Variants Distribution
Classified variants from ClinVar · 5 ACMG categories
| Classification | LoF | Missense + Inframe | Non-coding | Synonymous | Total |
|---|---|---|---|---|---|
Pathogenic | 0 | 0 | 46 | 0 | 46 |
Likely Pathogenic | 0 | 0 | 0 | 0 | 0 |
VUS | 0 | 70 | 6 | 0 | 76 |
Likely Benign | 0 | 4 | 0 | 3 | 7 |
Benign | 0 | 0 | 1 | 2 | 3 |
| Total | 0 | 74 | 53 | 5 | 132 |
LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly
View in ClinVar →Protein Context — Lollipop Plot
FOXO1 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
3D Protein StructureAlphaFold
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
Effect of Exercise Type on Muscle Quality in Patients With OA, SARC and RA: an Explorative Study
NOT YET RECRUITINGA Clinical Study on the Efficacy and Safety of All-trans Retinoic Acid Combined With VAC Regimen in the Treatment of Intermediate-to-high-risk Rhabdomyosarcoma
NOT YET RECRUITINGExternal Resources
Links to major genomics databases and tools